Samuel Dagogo-Jack
Monday
14.30 - 16.30
Villach
Building the Latest Scientific and Clinical Understanding for the Treatment of Patients with Type 2 Diabetes
Sam Dagogo-Jack (US)
Chris Cannon (US)
Tuesday
14.00 - 14.30
New Learnings from the VERTIS CV Outcome Trial for Our Patients with Type 2 Diabetes and Cardiovascular Disease
Samuel Dagogo-Jack (US)
Legal NoticeData Protection